• 제목/요약/키워드: supportive treatment

검색결과 354건 처리시간 0.026초

한의학 정신요법을 이용한 소아 전환장애 환자 1례 - 지언고론요법(至言高論療法), 지지적 정신치료와 행동치료 - (A Case Report about Treatment of Childhood Conversion Disorder with Psychotherapy of Oriental Medicine -The Giungoroen(至言高論), Supportive Psychotherapy and Behavioral Therapy-)

  • 서현욱;서진우;황은영;김종우;정선용
    • 동의신경정신과학회지
    • /
    • 제20권4호
    • /
    • pp.185-196
    • /
    • 2009
  • 통제적이고 강압적인 부모의 양육태도로 유발된 내면의 불안 및 갈등이 '항문의 이상 감각'이라는 신체화 증상으로 상징화되어 표출된, 전환장애로 의심되는 7세 여환아(女患兒)에게 한약(韓藥)치료와 더불어 지언고론요법(至言高論療法)을 적용하여 약 2개월간 치료하였다. 지언고론요법(至言高論療法)은 한의학 정신요법 중 하나로 현재 임상에서 행해지고 있는 지지적 정신치료 및 행동치료와 유사하다. 의료진은 이를 본 증례의 환아(患兒)에게 2개월간 적용하여 증상이 80%이상 소실되는 긍정적인 치료 결과를 얻을 수 있었다. 아동의 심리 발달과정에서 부모의 양육태도 등과 같은 중요한 심리 환경적 요인들이 부적절하여 아동의 내면에 갈등이 생기면 심인성의 신체증상이 유발되기도 한다. 이는 전환장애의 심리기제와 매우 흡사하다 할 수 있다. 그러므로 아동의 심인성 신체 증상을 치료하는 장면에서, 우선 성장 환경의 문제점 혹은 환아(患兒)의 성격 기질적 특성을 정확히 파악하고 그에 따라 지언고론요법(至言高論療法)등과 같은 한의학 정신요법을 이용해 적절한 치료적 개입을 한다면 이른 시간 안에 효과적인 치료가 가능할 것이다. 본 증례는 그 좋은 예라 사료된다.

  • PDF

Association of chairside salivary aMMP-8 findings with periodontal risk assessment parameters in patients receiving supportive periodontal therapy

  • Schmalz, Gerhard;Kummer, Max Kristian;Kottmann, Tanja;Rinke, Sven;Haak, Rainer;Krause, Felix;Schmidt, Jana;Ziebolz, Dirk
    • Journal of Periodontal and Implant Science
    • /
    • 제48권4호
    • /
    • pp.251-260
    • /
    • 2018
  • Purpose: The aim of this retrospective cross-sectional study was to evaluate whether salivary findings of active matrix-metalloproteinase 8 (aMMP-8) chairside (point of care; POC) tests were associated with periodontal risk assessment parameters in patients receiving supportive periodontal therapy (SPT). Methods: A total of 125 patients receiving regular SPT were included, and their records were examined. The following inclusion criteria were used: a diagnosis of chronic periodontitis, at least 1 non-surgical periodontal treatment (scaling and root planning) with following regular SPT (minimum once a year), at least 6 remaining teeth, and clinical and aMMP-8 findings that were obtained at the same appointment. In addition to anamnestic factors (e.g., smoking and diabetes), oral hygiene indices (modified sulcus bleeding index [mSBI] and approximal plaque index), periodontal probing depth simultaneously with bleeding on probing, and dental findings (number of decayed, missing, and filled teeth) were recorded. Salivary aMMP-8 levels were tested using a commercial POC test system (Periomarker, Hager & Werken, Duisburg, Germany). Statistical analysis was performed using the t-test, Mann-Whitney U test, Fisher's exact test, and ${\chi}^2$ test, as appropriate (P<0.05). Results: Only the mSBI was significantly associated with positive salivary aMMP-8 findings (aMMP-8 positive: $27.8%{\pm}20.9%$ vs. aMMP-8 negative: $18.0%{\pm}14.5%$; P=0.017). No significant associations were found between aMMP-8 and smoking, diabetes, periodontal parameters, or parameters related to the maintenance interval (P>0.05). Conclusions: Salivary aMMP-8 chairside findings were not associated with common parameters used for periodontal risk assessment in patients receiving SPT. The diagnostic benefit of POC salivary aMMP-8 testing in risk assessment and maintenance interval adjustment during SPT remains unclear.

Synergistic Effects of Jerusalem Artichoke in Combination with Pegylated Interferon Alfa-2a and Ribavirin Against Hepatic Fibrosis in Rats

  • Abdel-Hamid, Nabil Mohie;Wahid, Ahmed;Nazmy, Maiiada Hassan;Eisa, Marwa Abdel-Moniem
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권4호
    • /
    • pp.1979-1985
    • /
    • 2016
  • Background: Complementary and alternative medicine has been highly appreciated as a supportive regimen for classical treatment strategies. Here we offer a nutrition-based adjuvant therapy for liver fibrosis, a major risk factor for cirrhosis and hepatocellular carcinoma. Aim of the study: To evaluate the possible hepatoprotective effects of Jerusalem artichoke tubers (JAT) in combination with interferon and ribavirin. Materials and Methods: Twelve groups of rats were administered JAT, interferon and ribavirin either separately or in combination from day one of $CCL_4$ administration until the end of the study. Animals were killed after 8 weeks of $CCL_4$-induced hepatotoxicity. Results: Hepatocytes from rats treated with triple combination of interferon, ribavirin, and JAT showed more less normal architecture compared to $CCL_4$-treated rats. We also detected significantly higher hepatic protein expression levels of p53, BAX and transforming growth factor-${\beta}$ (TGF-${\beta}$) in the $CCL_4$-intoxicated group compared to normal controls, as evidenced by immunohistochemical staining and western blotting analyses. Addition of JAT as a supportive regimen improved response to ribavirin and interferon and effectively participated in retaining normal histopathological and biochemical criteria and significantly lowered protein expression of p53, BAX, and TGF-${\beta}$. Conclusions: We suggest that addition of JAT as a supportive r egimen to interferon and ribavirin effectively potentiates their anti-fibrotic effects.

Aggressive Treatment of Performance Status 1 and 2 HCC Patients Significantly Improves Survival - an Egyptian Retrospective Cohort Study of 524 Cases

  • Aziz, Ashraf Omar Abdel;Omran, Dalia;Nabeel, Mohamed Mahmoud;Elbaz, Tamer Mahmoud;Abdelmaksoud, Ahmed Hosni;Attar, Inas El;Shousha, Hend Ibrahim
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권5호
    • /
    • pp.2539-2543
    • /
    • 2016
  • Background: In the Barcelona Clinic Liver Cancer (BCLC) system, only sorafenib is suggested for HCC patients having performance status (PS) 1 or 2 even if they have treatable lesions. In the current study, we aimed to explore the outcome of using aggressive treatment for HCC patients with PS 1 and 2. Materials and Methods: Five hundred and twenty four patients with HCC were enrolled in this study and divided into 2 groups: 404 PS 1 and 120 PS 2. Of the included 524 patients, 136 recceived non-aggressive supportive treatment and sorafenib, while 388 patients were offered aggressive treatment in the form of surgical resection, transplantation, percutaneous ablation, trans-arterial chemoembolization and/or chemoperfusion. All the patients were followed up for a period of 2 years to determine their survival. Results: Most HCC patients were CHILD A and B grades (89.4% versus 85.0%, for PS1 and PS2, respectively). Patients with PS1 were significantly younger. Out of the enrolled 524 patients, 388 were offered aggressive treatment, 253 (65.2%) having their lesions fully ablated, 94 (24.2%) undergoing partial ablation and 41 patients with no ablation (10.6%). The median survival of the patients with PS 1 who were offered aggressive treatment was 20 months versus 9 months only for those who were offered supportive treatment and sorafenib (p<0.001). Regarding HCC patients with PS 2, the median survivals were similarly 19.7 months versus 8.7 months only (p<0.001). Conclusions: Aggressive treatment of HCC patients with PS 1 and 2 significantly improves their survival. Revising the BCLC guidelines regarding such patients is recommended.

4기 비소세포폐암 환자에서 복합화학요법군과 보존적치료군의 생존율 비교연구 (Survival Difference of Combination Chemotherapy versus Supportive Care in the Patients with Stage Ⅳ Non-Small Cell Lung Cancer)

  • 김병훈;이경희;도갑석;이은정;김성목;정진홍;이관호;현명수
    • Tuberculosis and Respiratory Diseases
    • /
    • 제43권4호
    • /
    • pp.536-546
    • /
    • 1996
  • 연구배경 : 복합화학요법이 진행성, 특히 원격전이를 가진 4기 비소세포폐암 환자들의 생존율을 향상시킬 수 있는 지에 대해서는 아직까지 논란의 대상이 되고 있다. 이에 저자들은 원격전이가 증명된 4기 비소세포폐암 환자에서 cis-platin을 근간으로 한 복합화학요법군과 보존적 치료군의 생존율 차이를 평가하고, 생존율에 영향을 미칠 수 있는 예후 인자를 조사하여 보고하고자 한다. 방법 : 대상환자는 1989년 1월부터 1994년 12월까지 5년간 영남대학교 의과대학 부속병원에 내원하여 조직병리학적으로 비소세포폐암으로 진단된 환자 중 원격전이가 증명된 4기 환자, 총 89명에서 평가 가능한 환자 67명을 대상으로 하였고, 67명의 환자를 항암화학요법군과 보존적 치료군으로 나누고 항암화학요법군은 다시 반응군과 비반응군으로 나누어 생존율과 예후인자를 조사하였다. 결과 : 1) 4기 비소세포폐암 환자에서 생존율에 영향을 주는 의미있는 예후인자는 ECOG 기준에 따른 전신수행상태와 조직형이었다. 2) 전체 대상환자의 중앙생존기간은 13.6주였고 복합화학요법군의 중앙생존지간은 20주로써 보존적 치료군의 11.7주에 비해 길었다(p<0.01). 3) 복합화학요법에 반응이 있었던 환자들의 중앙생존기간은 45.5주로써 비반응군의 17.3주에 비해 의미있게 길었다(p<0.05). 4) 복합화학요법군의 1년 생존율은 15%, 보존적 치료군은 8%였다. 5) 복합화학요법의 부작용은 비교적 수용할 만 했다. 결론 : 전신수행상태가 양호하고 젊은 4기 비소세포폐암 환자들에 대해서 보다 적극적인 항암화학치료가 필요할 것으로 사료되며 앞으로 많은 환자를 대상으로 한 전향적 연구가 이루어져야 할 것이다.

  • PDF

선천성 식도폐쇄 및 기관식도루 수술치험 2례 (The Surgical Treatment of Esophageal Atresia with Tracheoesophageal Fistula -Report of 2 Cases-)

  • 한동기
    • Journal of Chest Surgery
    • /
    • 제27권3호
    • /
    • pp.244-250
    • /
    • 1994
  • Early recognition, vigorous preoperative preparation, sophisticated supportive care, control of sepsis, and intensive care nursing have produced remarkably improved results in the management of esophageal atresia. Successful surgery for esophageal atresia and tracheoesophageal fistula was carried out recently. Two neonates with esophageal atresia and distal tracheoesophageal fistula were type C. Transpleural end-to-end repair was carried out after gastrostomy due to low birth weight in case I associated with ventricular septal defect. Case 2 underwent primary retropleural end-to-end repair. A simple one-layer anastomosis with the sutures passing through all layers of`the esophagus was performed in all cases.

  • PDF

임프란트 주위염의 이해와 치료 (Treatment considerations in peri-implantitis)

  • 김보배;고영경;박준범
    • 대한치과의사협회지
    • /
    • 제53권5호
    • /
    • pp.318-325
    • /
    • 2015
  • Peri-implantitis is defined as an inflammatory process affecting the tissues around an osseointegrated implant, resulting in the loss of the supporting bone. Microbial adherence and colonization appear to play a major role in the pathogenesis of periimplantitis. The decision regarding treatment strategies is based on the diagnosis. The severity of the peri-implant lesion and the treatment strategies must include mechanical cleaning (infection control) procedures. Mechanical instrumentation is widely used for the debridement of dental implants, but this may alter the titanium's surface properties. Therefore, selection of the type of instrumentation should be made depending on the type of surface to be debrided. Also, patients with dental implants must always be enrolled in a supportive therapy program.

국소성 농포성 건선 치험 1례 (A Case of Localized Pustular Psoriasis)

  • 조준기;조은희;김경준;박민철
    • 한방안이비인후피부과학회지
    • /
    • 제19권2호
    • /
    • pp.313-319
    • /
    • 2006
  • Background and Objective : Localized Pustular Psoriasis(LPP) is a rare form of psoriasis characterized by erythematous papules, plaques studded with pustules(usually on palms or soles) However, the pathophysiology of the LPP remains obscure. Treatment at present is symptomatic and supportive. There is no report on LPP treated with oriental medical treatment. Methods : We conducted one patient with LPP seen at Won-Kwang University Ik-San Oriental Medical Hospital in 2003. We treated LPP in a forty-nine years old man by a herbal medicine, acupuncture, moxa, etc Conclusions : We had a significant results. So we report this case to estimate the efficiency of oriental medic at treatment and management on LPP

  • PDF

Stevens-Johnson 증후군;증례보고 및 문헌고찰 (STEVENS-JOHNSON SYNDROME;A CASE REPORT AND LITERATURE REVIEW)

  • 서재훈;여환호;김영균
    • Maxillofacial Plastic and Reconstructive Surgery
    • /
    • 제17권1호
    • /
    • pp.82-89
    • /
    • 1995
  • The Stevens-Johnson syndrome is a severe form of erythema multiforme associated with multiple organ involvement that can result in severe mortality. There are many etiologic factors including drugs, infection, or stress ; but accurate pathogenesis is still obscure. Treatments are composed of the removal of possible etiologic factors, symptomatic and supportive treatment. We experienced a case of Stevens-Johnson syndrome with involvement of generalized skin, oral mucosa, and eye involvement. This patient was treated by symptomatic and preventive method including corticosteroid, antihystamine, and opthalmic treatment.

  • PDF

알레르기성 자반증의 증례 보고 2례 (Two Cases Report of Allergic Purpura)

  • 조준기;김환영;안찬근;윤채성;조은희;박민철
    • 한방안이비인후피부과학회지
    • /
    • 제20권3호
    • /
    • pp.260-267
    • /
    • 2007
  • Background and Objective : Allergic purpura is a generalized vasculitis characterized by cutaneous purpura, art hritis, abdominal pain, gastrointestinal bleeding and nephritis. However, the pathophysiology of the Allergic purpura remains obscure. Treatment at present is symptomatic and supportive. There is few reports on Allergic purpura treated with oriental medical treatment. Methods : We conducted two patients with Allergic purpura seen at Won-Kwang University Ik-San Oriental Medical Hospital. We treated Allergic purpura by a herbal medicine, acupunture, etc. Conclusions : We suggest that the oriental medical treatment and management have an effect with Allergic purpura which means Podoyug in Oriental medicine.

  • PDF